查找临床试验

已按「胆管癌」检索,对应国际通用词 cholangiocarcinoma

试验不在中国怎么办?

共找到 12 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 11:18,每 5 分钟自动同步
正在招募II 期中国有中心NCT06280508

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

China

年龄 18 Years不限

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募II 期中国有中心NCT07105852

Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

China

年龄 18 Years不限

Sir Run Run Shaw Hospital

正在招募早期 I 期中国有中心NCT07595237

A IIT Study of 177Lu-DOTA-SNA040

China

年龄 18 Years75 Years

SmartNuclide Biopharma

正在招募I 期 / II 期中国有中心NCT06730009

Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients

Taiwan

年龄 18 Years不限

Medigen Biotechnology Corporation

正在招募I 期中国有中心NCT07106827

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

China

年龄 18 Years不限

West China Hospital

正在招募II 期中国有中心NCT07398339

Cosiporfin Sodium for Injection Photodynamic Therapy

China

年龄 18 Years不限

Shanghai Guangsheng Biopharmaceutical Co., Ltd

正在招募不适用中国有中心NCT04078230

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

United States、China

年龄 18 Years80 Years

Second Affiliated Hospital, Zhejiang University, School of Medicine

正在招募III 期中国有中心NCT05823311

Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma

China

年龄 18 Years75 Years

Second Affiliated Hospital, Zhejiang University, School of Medicine

正在招募II 期中国有中心NCT06860477

Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)

China

年龄 18 Years不限

Fudan University

正在招募不适用中国有中心NCT07263217

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

China

年龄 18 Years75 Years

Second Affiliated Hospital, Zhejiang University, School of Medicine

正在招募不适用中国有中心NCT06487663

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

China

年龄 18 Years75 Years

Tianjin Medical University Cancer Institute and Hospital

正在招募III 期中国有中心NCT05342194

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

China

年龄 18 Years75 Years

Shanghai Junshi Bioscience Co., Ltd.